Loading of VEGF to the heparin cross-linked demineralized bone matrix improves vascularization of the scaffold
Authors:
- 26 July 2009
- journal article
- research article
- Published by Springer Nature in Journal of Materials Science: Materials in Medicine
- Vol. 21 (1) , 309-317
Abstract
Deficient vascularization is one of the prominent shortcomings of porous tissue-engineering scaffolds, which results in insufficient oxygen and nutrients transportation. Here, heparin cross-linked demineralized bone matrices (HC-DBM) pre-loaded with vascular endothelial growth factor (VEGF) were designed to promote cells and new microvessels invasion into the matrices. After being chemical crosslinked with heparin by N-hydroxysuccinimide and N-(3-di-methylaminopropyl)-N’-ethylcarbodiimide, the scaffold could bind more VEGF than the non-crosslinked one and achieve localized and sustained delivery. The biological activity of VEGF binding on heparinized collagen was demonstrated by promoting endothelial cells proliferation. Evaluation of the angiogenic potential of heparinized DBM loaded with VEGF was further investigated by subcutaneous implantation. Improved angiogenesis of heparinized DBM loaded with VEGF was observed from haematoxylin-eosin staining and immunohistochemistry examination. The results demonstrated that heparin cross-linked DBM binding VEGF could be a useful strategy to stimulate cells and blood vessels invasion into the scaffolds.Keywords
This publication has 44 references indexed in Scilit:
- The effect of sustained delivery of vascular endothelial growth factor on angiogenesis in tissue-engineered intestineBiomaterials, 2008
- Impaired osteoinduction in a rat model for chronic alcohol abuseBone, 2007
- In Vitro and In Vivo Effects of Deoxyribonucleic Acid–Based Coatings Funtionalized with Vascular Endothelial Growth FactorTissue Engineering, 2007
- Effects of growth factors on heparin‐carrying polystyrene‐coated atelocollagen scaffold for articular cartilage tissue engineeringJournal of Biomedical Materials Research Part B: Applied Biomaterials, 2007
- Activation of demineralized bone matrix by genetically engineered human bone morphogenetic protein‐2 with a collagen binding domain derived from von Willebrand factor propolypeptideJournal of Biomedical Materials Research Part A, 2006
- Stimulation of in vivo angiogenesis using dual growth factor-loaded crosslinked glycosaminoglycan hydrogelsBiomaterials, 2006
- Modulation of Angiogenic Potential of Collagen Matrices by Covalent Incorporation of Heparin and Loading with Vascular Endothelial Growth FactorTissue Engineering, 2004
- The biology of VEGF and its receptorsNature Medicine, 2003
- Physiological and pathological angiogenesis in the endocrine systemMicroscopy Research and Technique, 2002
- Tumor angiogenesis and accessibility: Role of vascular endothelial growth factorSeminars in Oncology, 2002